Abstract
Recent evidence in the literature strongly suggest that the receptor vitronectin , the alphavbeta3 integrin is an important pharmacological target in preventing metastases. In our laboratory was standardized methodology for silencing transient beta3 subunit of integrin alphavbeta3 with the aim of studying the role this receptor in the tumor microenvironment and transmigration of tumor cel…